Incredulous researchers, at first puzzled by the results of their animal experiment with mice, continued to increase the human equivalent dosage up to 7000 mg, prolonged the duration of the study up to six months, and even administered Longevinex to another animal species, rabbits, with the same results.
Resveratrol antioxidant or pro-oxidant?
In prior animal studies it has been shown that as dosage increases resveratrol shifts from being an antioxidant to a pro-oxidant (promotes oxidation) it binds to copper at low doses and releases copper at high doses. Longevinex exhibited no such toxicity. This remarkable range of safety for any resveratrol-based product has never been demonstrated before.
Animal studies show plain resveratrol is optimally cardio-protective at human-equivalent dose of 100-175 mg and begins to lose its protective effects in a dose as low as 350 mg. Published studies confirm that low-dose resveratrol, particularly when combined with other synergistic small molecules from nature as provided in Longevinex, works better in animal hearts than mega doses.
While this is the first time a resveratrol pill has been demonstrated to exhibit an L-shaped risk curve (risk goes down and stays down at all tested doses), this does not imply that mega-dose Longevinex is totally without side effect at all doses, says Bill Sardi, spokesperson for Longevinex. Consumers should refer to the product label which describes recommended dosage range and potential side effects with resveratrol pills, Sardi says.
Researchers indicate low-dose resveratrol protects the heart from damage should a heart attack occur, while "plain resveratrol should only be used at lower doses as opposite effects can occur higher doses, resulting in adverse effects on health."
Longevinex is the first branded resveratrol product to sh
|Contact: Bill Sardi|
Resveratrol Partners LLC, dba LONGEVINEX